ClinicalTrials.gov record
Completed Phase 1 Interventional

Curcumin Biomarkers

ClinicalTrials.gov ID: NCT01333917

Public ClinicalTrials.gov record NCT01333917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 1:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Curcumin Chemoprevention of Colorectal Neoplasia

Study identification

NCT ID
NCT01333917
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
University of North Carolina, Chapel Hill
Other
Enrollment
40 participants

Conditions and interventions

Interventions

  • Curcumin C3 tablet Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2010
Primary completion
Sep 30, 2011
Completion
Dec 31, 2012
Last update posted
Feb 6, 2013

2010 – 2013

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
UNC Department of Family Medicine Chapel Hill North Carolina 27599

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01333917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2013 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01333917 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →